<DOC>
	<DOCNO>NCT00420784</DOCNO>
	<brief_summary>The PROVE3 trial partially double blind , randomize , Phase 2 research study investigational drug , Telaprevir ( VX-950 ) Placebo , Pegylated Interferon Alfa 2a ( Peg-IFN-alfa-2a , Pegasys速 ) , Ribavirin ( RBV , Copegus速 ) people genotype 1 hepatitis C achieve Sustained Viral Response ( SVR ) previous treatment interferon therapy .</brief_summary>
	<brief_title>A Study Telaprevir ( VX-950 ) , Pegasys Copegus Hepatitis C ( PROVE3 )</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<mesh_term>Peginterferon alfa-2a</mesh_term>
	<criteria>Males females 18 70 year old Detectable plasma hepatitis C virus ( HCV ) ribonucleic acid ( RNA ) great equal ( &gt; = ) 10,000 international unit per milliliter ( IU/mL ) Must chronic hepatitis C ( genotype 1 ) already receive least one prior course pegylated interferon alfa 2a ribavirin Can also infect Human Immunodeficiency Virus hepatitis B Must judge general good health able receive Pegasys速 Copegus速 No drug alcohol abuse last year Must agree use two effective method birth control study 6 month stop take study medication . One method need 'barrier ' method ( condom diaphragm ) If woman , study pregnant nursing Participation clinical trial HCV protease inhibitor duration Prior response therapy failure achieve SVR due treatment noncompliance Any cause significant liver disease addition hepatitis C ; may include limited , hepatitis B , drug alcoholrelated cirrhosis , autoimmune hepatitis , hemochromatosis , Wilson 's disease , nonalcoholic steatohepatitis , primary biliary cirrhosis Diagnosed suspected hepatocellular carcinoma History current evidence decompensated liver disease Participation clinical trial investigational drug within 90 day drug administration participation 2 drug study last 12 month ( exclusive current study )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Genotype 1</keyword>
</DOC>